A61K 51/0468
Having seven-membered rings
Official title: {having seven-membered rings, e.g. azelastine, pentylenetetrazole}
A61K51/0468 (Having seven-membered rings) appears on 48 US grants and 75 published applications in this corpus.
Search patents in A61K- Granted patents
- 48
- Published applications
- 75
- Assignees
- 46
- Inventors
- 220
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 3 |
| 2005 | 4 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 2 |
| 2011 | 1 | 5 |
| 2012 | 1 | 4 |
| 2013 | 2 | 5 |
| 2014 | 3 | 7 |
| 2015 | 4 | 2 |
| 2016 | 1 | 3 |
| 2017 | 5 | 2 |
| 2018 | 2 | 2 |
| 2019 | 0 | 3 |
| 2020 | 2 | 5 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 1 | 4 |
| 2025 | 2 | 6 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Granzyme B directed imaging and therapy17 Feb 2026US 12,551,582 B2CytoSite Biopharma Inc.
- Cholecystokinin B receptor targeting for imaging and therapy2 Dec 2025US 12,485,179 B2Purdue Research Foundation
- Granzyme B directed imaging and therapy11 Mar 2025US 12,246,075 B2The General Hospital Corporation
- Compounds and probes for imaging huntingtin protein28 May 2024US 11,992,535 B2CHDI Foundation, Inc.
- Granzyme B directed imaging and therapy6 Jun 2023US 11,667,645 B2CytoSite Biopharma Inc.
- Small molecule tracers binding to alpha-synuclein aggregates and their uses23 Jul 2026US 2026/0207795 A1Fudan University
- Compounds specific to granzyme b and uses thereof11 Jun 2026US 2026/0158177 A1CytoSite Biopharma Inc.
- Methods of diagnosing and treating neurodegenerative diseases29 May 2025US 2025/0170124 A1The General Hospital Corporation
- Compounds specific to granzyme b and uses thereof27 Feb 2025US 2025/0064991 A1CytoSite Biopharma Inc.
- Imaging method for designer receptor, antagonist or agonist, pharmaceutical, and companion diagnostic agent27 Feb 2025US 2025/0064992 A1National Institutes for Quantum and Radiological Science and Technology
Most cited
By later US patents
- Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites66US 4,574,079 A1986
- Amyloid plaque aggregation inhibitors and diagnostic imaging agents50US 6,696,039 B2The Trustees of the University of Pennsylvania · 2004
- Amyloid plaque aggregation inhibitors and diagnostic imaging agents29US 6,946,116 B2The Trustees of the University of Pennsylvania · 2005
- Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging15US 6,878,363 B2Bristol-Myers Squibb Pharma Company · 2005
- Methods and compositions for plasma and organ imaging12US 4,606,908 AWashington Research Foundation · 1986